Maxim Korolev

5PUBLICATIONS
57CO-AUTHORS
AutoimmunityPredictive and prognostic markersDisease surveillanceOptometryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 31, 2026
The role of PD-1 and Tim-3 in regulating the suppressive activity of myeloid-derived suppressor cells in axial spondyloarthritis: association with clinical and laboratory parameters.

Tamara Viktorovna Tyrinova, Ludmila Vasilievna Sakhno, Ivan Vladimirovich Savkin

|Nov 27, 2025
Modern Strategies for Osteoporosis Therapy: Current Status and Prospects for Targeted Intervention.

Vitalii Omelchenko, Vladimir Koval, Natalya Slazhneva

|May 12, 2025
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA.

E L Nasonov, V I Mazurov, A M Lila

|Oct 02, 2024
Osteopoikilosis in a young ankylosing spondylitis patient.

Vitaly Omelchenko, Elena Letyagina, Maxim Korolev

|Oct 26, 2022
[Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugs].

M A Korolev, E A Letyagina, A E Sizikov

Pageof 1

Frequent Collaborators

4 joint publications

Vitaly Omelchenko

3 joint publications

Elena Letyagina

2 joint publications

Aleksey Eduardovich Sizikov

2 joint publications

Oksana Aleksandrovna Chumasova